PPG sells its ownership interest in transitions optical joint venture to Essilor International

NewsGuard 100/100 Score

PPG Industries, Inc. (NYSE:PPG) today announced the successful completion of the previously announced sale to Essilor International of its 51 percent ownership interest in its Transitions Optical joint venture and PPG's wholly-owned sunlens business. Essilor International had held a 49 percent interest in the Transitions Optical joint venture.

As previously indicated, the transaction reflects an enterprise value of approximately $3.4 billion, with PPG receiving cash at closing of $1.73 billion pre-tax or approximately $1.5 billion after-tax, subject to certain post-closing adjustments and transaction costs. In 2013, the Transitions Optical joint venture and sunlens business had combined net sales of $874 million.

Currently, all Transitions Optical sales are consolidated in PPG's financial statements. Essilor's minority share of the joint venture's net earnings is reflected as a reduction to PPG's net income and presented in the financial statements as "income attributable to non-controlling interests." In accordance with Generally Accepted Accounting Principles (GAAP), the Transitions Optical joint venture and sunlens business results will be classified as "Discontinued Operations" in future PPG financial releases. Prior periods will be recast to conform to this presentation. In addition, PPG has updated its 2014 tax rate guidance on ongoing earnings from continuing operations, with the company now anticipating this rate to be in the range of 23.5 percent to 24.5 percent.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.